no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A large proportion of intravenously administered methamphetamine is excreted into the stomach
|
Moriya, Fumio |
|
2013 |
32 |
1 |
p. 186-188 |
article |
2 |
Analysis of 11-nor-9-carbonyl-∆9-tetrahydrocannabinol in human blood and bile by liquid chromatography–tandem mass spectrometry after derivatization with ethyl chloroformate and amines
|
Yamaguchi, Koji |
|
2013 |
32 |
1 |
p. 51-58 |
article |
3 |
An LC–MS–MS method for quantitation of four new phenethylamines (BOX series) in plasma: in vivo application
|
Boatto, Gianpiero |
|
2013 |
32 |
1 |
p. 75-81 |
article |
4 |
Application of modified QuEChERS method to liver samples for forensic toxicological analysis
|
Usui, Kiyotaka |
|
2013 |
32 |
1 |
p. 139-147 |
article |
5 |
A simple method for the simultaneous determination of mushroom toxins by liquid chromatography–time-of-flight mass spectrometry
|
Yoshioka, Naoki |
|
2013 |
32 |
1 |
p. 89-96 |
article |
6 |
Cross-reactivities of 39 new amphetamine designer drugs on three abuse drugs urinary screening tests
|
Nieddu, Maria |
|
2013 |
32 |
1 |
p. 132-138 |
article |
7 |
Development of ultrasound-assisted dispersive liquid–liquid microextraction–large volume injection–gas chromatography–tandem mass spectrometry method for determination of pyrethroid metabolites in brain of cypermethrin-treated rats
|
Mudiam, Mohana Krishna Reddy |
|
2013 |
32 |
1 |
p. 19-29 |
article |
8 |
Erratum to: Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products
|
Uchiyama, Nahoko |
|
2013 |
32 |
1 |
p. 116-117 |
article |
9 |
Fentanyl: cause of death or incidental finding? Postmortem peripheral blood concentrations with and without documented transdermal patch use
|
Lung, Derrick D. |
|
2013 |
32 |
1 |
p. 118-125 |
article |
10 |
High-throughput analysis of ramelteon, agomelatine, and melatonin in human plasma by ultra-performance liquid chromatography–tandem mass spectrometry
|
Ogawa, Tadashi |
|
2013 |
32 |
1 |
p. 126-131 |
article |
11 |
Homicide–suicide by oral administration of cyclobarbital
|
Torimitsu, Suguru |
|
2013 |
32 |
1 |
p. 180-185 |
article |
12 |
Identification and quantitation of N,α-diethylphenethylamine in preworkout supplements sold via the Internet
|
Lee, Jaesin |
|
2013 |
32 |
1 |
p. 148-153 |
article |
13 |
Identification of a synthetic cannabinoid A-836339 as a novel compound found in a product
|
Uemura, Nozomi |
|
2013 |
32 |
1 |
p. 45-50 |
article |
14 |
Identification of two new-type designer drugs, piperazine derivative MT-45 (I-C6) and synthetic peptide Noopept (GVS-111), with synthetic cannabinoid A-834735, cathinone derivative 4-methoxy-α-PVP, and phenethylamine derivative 4-methylbuphedrine from illegal products
|
Uchiyama, Nahoko |
|
2013 |
32 |
1 |
p. 9-18 |
article |
15 |
Interpretation of a highly positive ethyl glucuronide result together with negative fatty acid ethyl esters result in hair and negative blood results
|
Kintz, Pascal |
|
2013 |
32 |
1 |
p. 176-179 |
article |
16 |
MALDI-TOF mass spectrometric determination of four pyrrolidino cathinones in human blood
|
Minakata, Kayoko |
|
2013 |
32 |
1 |
p. 169-175 |
article |
17 |
Metabolism of the newly encountered designer drug α-pyrrolidinovalerophenone in humans: identification and quantitation of urinary metabolites
|
Shima, Noriaki |
|
2013 |
32 |
1 |
p. 59-67 |
article |
18 |
Occurrence of postmortem production of ethylene glycol and propylene glycol in human specimens
|
Wurita, Amin |
|
2013 |
32 |
1 |
p. 162-168 |
article |
19 |
Presence of appreciable amounts of ethylene glycol, propylene glycol, and diethylene glycol in human urine of healthy subjects
|
Wurita, Amin |
|
2013 |
32 |
1 |
p. 39-44 |
article |
20 |
Rapid and simultaneous extraction of acidic and basic drugs from human whole blood for reliable semi-quantitative NAGINATA drug screening by GC–MS
|
Kudo, Keiko |
|
2013 |
32 |
1 |
p. 97-104 |
article |
21 |
Recently abused synthetic cathinones, α-pyrrolidinophenone derivatives: a review of their pharmacology, acute toxicity, and metabolism
|
Zaitsu, Kei |
|
2013 |
32 |
1 |
p. 1-8 |
article |
22 |
Simultaneous and sensitive analysis of fourth-generation antidepressants in human plasma by ultra-performance liquid chromatography–tandem mass spectrometry
|
Iwakura, Kenya |
|
2013 |
32 |
1 |
p. 30-38 |
article |
23 |
Simultaneous determination of tryptamine analogues in designer drugs using gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry
|
Nakazono, Yukiko |
|
2013 |
32 |
1 |
p. 154-161 |
article |
24 |
Synthetic cannabinoids abused in South Korea: drug identifications by the National Forensic Service from 2009 to June 2013
|
Chung, Heesun |
|
2013 |
32 |
1 |
p. 82-88 |
article |
25 |
Time-course profile of urinary excretion of intravenously administered α-pyrrolidinovalerophenone and α-pyrrolidinobutiophenone in a human
|
Namera, Akira |
|
2013 |
32 |
1 |
p. 68-74 |
article |
26 |
Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products
|
Uchiyama, Nahoko |
|
2013 |
32 |
1 |
p. 105-115 |
article |